News Nicox Glaucoma Drug Effective in Late-Stage Studies by Medscape • 2014/09/26 • 0 Comments French pharmaceutical firm Nicox unveiled positive topline Phase 3 results for its glaucoma drug and said, if approved by regulators, the product could reach peak annual sales of over $1 billion worldwide. Reuters Health Information Full Story →